The store will not work correctly when cookies are disabled.
1-3-[4-(tert-butyl) phenyl]-5-N,N-dimethylamino-(1,2,4-triazol-4-yl)]-4-phenol
ID: ALA1162931
PubChem CID: 11667199
Max Phase: Preclinical
Molecular Formula: C20H24N4O
Molecular Weight: 336.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)c1nnc(-c2ccc(C(C)(C)C)cc2)n1-c1ccc(O)cc1
Standard InChI: InChI=1S/C20H24N4O/c1-20(2,3)15-8-6-14(7-9-15)18-21-22-19(23(4)5)24(18)16-10-12-17(25)13-11-16/h6-13,25H,1-5H3
Standard InChI Key: ZKNXMCKPBXLKLZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
3.6847 -0.9565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9703 -0.5440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9703 0.2810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6847 0.6935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3992 0.2810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3992 -0.5440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6847 -1.7815 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6847 1.5185 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3522 -2.2664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0972 -3.0511 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2722 -3.0511 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0173 -2.2664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2327 -2.0115 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1368 -2.0115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6196 -2.5635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0611 -1.2045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3083 -1.2045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0929 -0.9496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7060 -1.5016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5345 -2.3086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7499 -2.5635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4906 -1.2467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2753 -0.9918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7456 -2.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2357 -0.4621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 2 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 7 1 0
4 8 1 0
7 9 1 0
7 12 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
9 14 1 0
13 15 1 0
13 16 1 0
14 17 1 0
14 21 2 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
19 22 1 0
22 23 1 0
22 24 1 0
22 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 336.44 | Molecular Weight (Monoisotopic): 336.1950 | AlogP: 4.00 | #Rotatable Bonds: 3 |
Polar Surface Area: 54.18 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.50 | CX Basic pKa: 2.32 | CX LogP: 4.83 | CX LogD: 4.83 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.79 | Np Likeness Score: -1.16 |
References
1. Zhang Q, Keenan SM, Peng Y, Nair AC, Yu SJ, Howells RD, Welsh WJ.. (2006) Discovery of novel triazole-based opioid receptor antagonists., 49 (14): [PMID:16821764] [10.1021/jm0601250] |